Perspective Therapeutics (CATX) Dividends Paid - Common (2015)

Perspective Therapeutics' (CATX) quarterly Dividends Paid - Common came in at $368.0 in Q2 2015.

Perspective Therapeutics (CATX) Dividends Paid - Common (2015) Analysis & Trends

Perspective Therapeutics has disclosed Dividends Paid - Common across 1 years of filings, most recently posting $368.0 for Q2 2015.

Dividends Paid - Common for Q2 2015 came in at $368.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2017 was $368.0 (changed N/A YoY), and the FY2021 annual result was $9000.0, down 18.18% from the prior year.
Dividends Paid - Common came in at $368.0 for Q2 2015 at Perspective Therapeutics.
In the past five years, Dividends Paid - Common ranged from a high of $368.0 in Q2 2015 to a low of $368.0 in Q2 2015.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Dividends Paid - Common (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	1.10 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	337.00 Mn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	911.00 Mn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	-
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	-
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	-
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	16.00 Mn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	61.80 Mn
10	Perspective Therapeutics	308.74 Mn	308.74 Mn	-	-

Historic Data

Download Data

Date	Value
Jun 30, 2015	368.00
Jun 30, 2015	368.00